Fairscale Capital »

Eli Lilly & Co. shares owned by Fairscale Capital

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Fairscale Capital from 13F filings

Historical chart of Fairscale Capital investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Fairscale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Fairscale Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $476k 537 886.00
2024-06-30 $515k 547 941.60

More positions owned by Fairscale Capital

Vanguard S&p 500 Etf idx (VOO)
iShares S&P NA Tech. Sec. Idx (IGM)
NVIDIA Corporation (NVDA)
Vanguard Admiral Fds Inc equity (VOOV)
Apple (AAPL)
Pacer Fds Tr us cash cows 100 (COWZ)
Microsoft Corporation (MSFT)
Invesco Qqq Trust Series 1 (QQQ)
Visa (V)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Schwab Strategic Tr us dividend eq (SCHD)
Thermo Fisher Scientific (TMO)
UnitedHealth (UNH)
Facebook Inc cl a (META)

View all positions for Fairscale Capital

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
Pnc Financial Services
State Street Corporation
T. Rowe Price Associates
Jpmorgan Chase & Co
PRIMECAP Management Company
Geode Capital Management
Morgan Stanley
State Farm Mutual Automobile Insurance Company
International Assets Investment Management
Bank of America Corporation
Jennison Associates
Bank of New York Mellon

View all funds holding Eli Lilly & Co.